steep exposure-response relationship [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2015-10-27 10:18 (3395 d 18:33 ago) – Posting: # 15582
Views: 5,692

Hi Mahesh M,

❝ – What is the steep exposure-response relationship?


It means that the slope of the dose-response curve is steep. Remember that sometimes we can describe the curve roughly with the Michaelis-Menten equation, and sometimes we opt to throw a Hill constant into the game. If a drug has a steep curve than some other drug it usually implies that it will have a higher Hill slope (Hill coefficient).
Steep is not a qualitative term. I cannot put a figure to it for the definition of such a drug. Everything is relative and vague. But I venture the opinion that the more pronounced the steepness, the higher the chance that a regulator would like to see monitoring of blood levels or other exposure indicators during therapy.

❝ – What is the difference between NTDI and steep exposure-response relationship?


If you have an NTDI with a relatively steep exposure-response relationship then a "little" deviation in terms of exposure (dose) could easier cause the effect to be outside the therapeutic window with everything that implies for safety/efficacy.

❝ – Literature reference regarding List of drugs which have steep exposure-response relationship


Can't help.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,662 registered users;
21 visitors (0 registered, 21 guests [including 8 identified bots]).
Forum time: 04:51 CET (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5